This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cyclacel Limited. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Tsuyoshi Murofushi: Innovator in Nucleoside Synthesis
Introduction
Tsuyoshi Murofushi is a notable inventor based in Hiratsuka, Japan. He has made significant contributions to the field of chemistry, particularly in the synthesis of nucleosides that have therapeutic applications.
Latest Patents
Murofushi holds a patent for the "Preparation of intermediates useful in the synthesis of 2'-cyano-2′-deoxy-N4-palmitoyl-1-β-D-arabinofuranosylcytosine." This invention outlines a process for preparing a compound through a series of conversions, ultimately leading to a nucleoside that is therapeutically useful in the treatment and prevention of cancer. The steps involve converting specific compounds into intermediates that facilitate the synthesis of the final product.
Career Highlights
He is currently associated with Cyclacel Limited, a company focused on developing innovative cancer therapies. Murofushi's work has been instrumental in advancing the understanding and application of nucleoside synthesis in medical treatments.
Collaborations
Murofushi has collaborated with notable colleagues such as Gavin Wood and Robert Westwood, contributing to a dynamic research environment that fosters innovation.
Conclusion
Tsuyoshi Murofushi's contributions to the field of nucleoside synthesis highlight his role as an important inventor in the fight against cancer. His innovative processes and collaborations continue to pave the way for advancements in therapeutic applications.